ATE439143T1 - Hm1.24 verwertende krebsvakzine - Google Patents

Hm1.24 verwertende krebsvakzine

Info

Publication number: ATE439143T1
Authority: AT; Austria
Prior art keywords: cancer vaccine; exploitable; protein; transduced; antigen
Prior art date: 2002-10-30

Application number

AT03770047T

Other languages

English (en)

Inventor

Yong Kwee

Masaaki Kosaka

Yasuo Koishihara

Original Assignee

Chugai Pharmaceutical Co Ltd

Univ London

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-30

Filing date

2003-10-30

Publication date

2009-08-15

2003-10-30 Application filed by Chugai Pharmaceutical Co Ltd, Univ London filed Critical Chugai Pharmaceutical Co Ltd

2009-08-15 Application granted granted Critical

2009-08-15 Publication of ATE439143T1 publication Critical patent/ATE439143T1/de

Links

229940022399 cancer vaccine Drugs 0.000 title abstract 2
238000009566 cancer vaccine Methods 0.000 title abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
210000004443 dendritic cell Anatomy 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/57—Skin; melanoma

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Cell Biology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

AT03770047T 2002-10-30 2003-10-30 Hm1.24 verwertende krebsvakzine ATE439143T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2002316639		2002-10-30
PCT/JP2003/013954 WO2004039398A1 (en)	2002-10-30	2003-10-30	Hm1.24-utilizing cancer vaccines

Publications (1)

Publication Number	Publication Date
ATE439143T1 true ATE439143T1 (de)	2009-08-15

Family

ID=32211691

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03770047T ATE439143T1 (de)	2002-10-30	2003-10-30	Hm1.24 verwertende krebsvakzine

Country Status (7)

Country	Link
US (1)	US8652839B2 (de)
EP (1)	EP1559432B1 (de)
JP (1)	JP4716730B2 (de)
AT (1)	ATE439143T1 (de)
AU (1)	AU2003278603A1 (de)
DE (1)	DE60328814D1 (de)
WO (1)	WO2004039398A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080219974A1 (en) *	2002-03-01	2008-09-11	Bernett Matthew J	Optimized antibodies that target hm1.24
JP4794303B2 (ja) *	2003-10-10	2011-10-19	中外製薬株式会社	固形腫瘍治療剤
JP2006141208A (ja) *	2004-11-16	2006-06-08	Univ Of Tokushima	多発性骨髄腫、白血病、悪性リンパ腫、肺癌等の免疫療法剤
US8329186B2 (en)	2004-12-20	2012-12-11	Isu Abxis Co., Ltd	Treatment of inflammation using BST2 inhibitor
JP5562031B2 (ja)	2006-09-18	2014-07-30	ゼンコー・インコーポレイテッド	Ｈｍ１．２４を標的とする最適化抗体
EP2281579A1 (de)	2009-08-05	2011-02-09	BioNTech AG	Impfstoffzusammensetzung mit 5'-Cap-modifizierter RNA
CN107541513B (zh) *	2016-06-28	2020-11-17	深圳宾德生物技术有限公司	用于沉默cd317的小分子干扰rna、重组载体、药物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2640399A (en)	1998-02-25	1999-09-15	Chugai Seiyaku Kabushiki Kaisha	Method for immunochemically assaying anti-hm1.24 antibody
WO2001077362A1 (fr)	2000-04-06	2001-10-18	Chugai Seiyaku Kabushiki Kaisha	Dosage immunologique d'anticorps anti hm1 . 24
WO2002055675A1 (en) *	2001-01-15	2002-07-18	I.D.M. Immuno-Designed Molecules	Ancillary composition for the preparation of committed mature dendritic cells

2003
- 2003-10-30 AT AT03770047T patent/ATE439143T1/de not_active IP Right Cessation
- 2003-10-30 EP EP03770047A patent/EP1559432B1/de not_active Expired - Lifetime
- 2003-10-30 US US10/533,104 patent/US8652839B2/en active Active
- 2003-10-30 AU AU2003278603A patent/AU2003278603A1/en not_active Abandoned
- 2003-10-30 JP JP2004548092A patent/JP4716730B2/ja not_active Expired - Lifetime
- 2003-10-30 WO PCT/JP2003/013954 patent/WO2004039398A1/en active Application Filing
- 2003-10-30 DE DE60328814T patent/DE60328814D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1559432A4 (de)	2006-05-17
US20060153883A1 (en)	2006-07-13
AU2003278603A8 (en)	2004-05-25
DE60328814D1 (de)	2009-09-24
WO2004039398A1 (en)	2004-05-13
EP1559432B1 (de)	2009-08-12
US8652839B2 (en)	2014-02-18
EP1559432A1 (de)	2005-08-03
JP2006508094A (ja)	2006-03-09
AU2003278603A1 (en)	2004-05-25
JP4716730B2 (ja)	2011-07-06

Similar Documents

Publication	Publication Date	Title
NO20020348L (no)	2002-01-23	Peptid acceptor ligeringsmetoder
CY1112735T1 (el)	2016-02-10	Πολυπεπτιδια δυναμενα εκμαιευσης μιας ανοσιακης αντιδρασης εναντι του καρκινου
DK1448595T3 (da)	2007-02-19	Antimikrobielle polypeptider
WO2004024757A3 (en)	2004-04-29	Modified pna molecules
WO2003093296A3 (en)	2004-09-10	Kinase anchor protein muteins, peptides thereof, and related methods
NO20043353L (no)	2004-11-12	Antistoff-inneholdende opplosningsfarmasoytika
WO2005035003A3 (en)	2005-08-18	Compositions and methods for increasing drug efficiency
CY1105439T1 (el)	2010-04-28	Κυτταρα, μεθοδοι καλλιεργειας και η χρηση τους στη θepαπεια με αυτολογη μεταμοσχευση
CY1110793T1 (el)	2015-06-10	Εμβολιο φυματιωσης με βελτιωμενη αποτελεσματικοτητα
DE60332774D1 (de)	2010-07-08	Verbesserte sso7-polymerase-konjugat-proteine
DK1471926T3 (da)	2011-02-28	Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens
CY1116774T1 (el)	2017-03-15	Συνθεση η οποια περιεχει lip2a leishmania
ATE439143T1 (de)	2009-08-15	Hm1.24 verwertende krebsvakzine
DE60322613D1 (de)	2008-09-18	Frostschutzproteine aus Basidiomyceten
NO20073914L (no)	2004-03-10	Biologisk aktive peptider
CY1116649T1 (el)	2017-03-15	Τεχνητη dna αλληλουχια με βελτιστοποιημενη λειτουργια οδηγου σε 5' (5-utr) για βελτιωμενη εκφραση ετερολογων πρωτεϊνων σε φυτα
BR0214542A (pt)	2005-08-16	Célula hospedeira, sistema de expressão, e, processos de preparação de uma célula hospedeira, e de uma proteìna alvo
WO2005013904A3 (en)	2007-02-15	Sars nucleic acids, proteins, vaccines, and uses thereof
ATE346087T1 (de)	2006-12-15	Hepatitis e-virus aus dem schwein und dessen verwendungen
BR0316224A (pt)	2005-10-04	Sequência de dna da região genÈmica tcd de photorhabdus luminescens
ATE469171T1 (de)	2010-06-15	Neue insektizide proteine von bazillus thuringiensis
BR0010222A (pt)	2002-03-19	Vetores de expressão viral
DE602004023311D1 (de)	2009-11-05	Antigen-zufuhrsystem
CY1115280T1 (el)	2017-01-04	Μεθοδος ρυθμισης εκφρασης γονιδιου
BR0303226A (pt)	2004-12-21	Proteìnas de aderência e penetração de haemophilus

Legal Events

Date	Code	Title	Description
2010-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties